Fig. 2

Schematic illustration and therapeutic strategy of engineered live biotherapeutic products (eLBPs) in treating skin conditions and dysbiosis such as cutaneous wounds and malignant melanoma.

Schematic illustration and therapeutic strategy of engineered live biotherapeutic products (eLBPs) in treating skin conditions and dysbiosis such as cutaneous wounds and malignant melanoma.